Mirai Investments Acquires Ternum Cosmetics, Launches New CDMO Division

Mirai Investments has completed the acquisition of Ternum Cosmetics, a company based in Barberá del Vallés, Barcelona, with more than 30 years of experience in research, development, and innovation (R&D&i) for cosmetic and personal care products. This strategic move, announced on April 27, 2026, marks the launch of Mirai’s new cosmetics division, Labery, which will operate as a Contract Development and Manufacturing Organization (CDMO) offering end-to-end services from product ideation and formulation to manufacturing, packaging, and logistics.

The integration of Ternum Cosmetics into Labery strengthens Mirai’s position in the fragmented European cosmetics CDMO market by creating a vertically integrated platform with critical mass. Labery combines Ternum’s scientific and creative expertise with Mirai’s existing industrial capabilities, aiming for a projected group revenue exceeding €25 million by 2026.

Ternum Cosmetics brings a strong innovation engine to Labery, focusing on developing differentiated, efficacious, and industrially viable cosmetic products. This complements Mirai’s existing divisions in industrial electronics and metal transformation, broadening its industrial portfolio.

Labery’s full-service CDMO model addresses a key market gap in Europe, where many operators lack the scale or integration to manage formulation, manufacturing, and packaging under one roof. By consolidating these functions, Labery aims to accelerate product development cycles, improve operational efficiencies, and offer clients a seamless service experience.

Mirai Investments has not disclosed the financial terms of the acquisition. However, the combined group’s forecasted revenue of over €25 million by 2026 reflects significant growth ambitions. The deal is expected to generate synergies through cross-selling, shared R&D resources, streamlined supply chains, and consolidated manufacturing operations.

Industry experts note that this acquisition intensifies competitive pressure on smaller, fragmented CDMO players in the cosmetics sector. The move is likely to accelerate consolidation trends as competitors seek to build scale and integrate services to meet growing client demand for full-service solutions.

Looking ahead, Mirai plans to focus on integrating Ternum’s R&D teams with Labery’s manufacturing and packaging operations while maintaining innovation momentum. The company acknowledges challenges in aligning corporate cultures and managing operational complexity but remains confident in delivering a robust, differentiated offering to the cosmetics market.

With this acquisition, Mirai Investments positions itself as a key player in the European cosmetics CDMO landscape, leveraging scientific innovation and full-service capabilities to capture unmet market demand and drive growth.